Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model

PURPOSE: An oral cholera vaccine (OCV), Euvichol, with thimerosal (TM) as preservative, was prequalified by the World Health Organization (WHO) in 2015. In recent years, public health services and regulatory bodies recommended to eliminate TM in vaccines due to theoretical safety concerns. In this s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Vaccine Res
Main Authors: Lee, Eun Young, Lee, Sena, Rho, Semi, Kim, Jae-Ouk, Choi, Seuk Keun, Lee, Young Jin, Park, Joo Young, Song, Manki, Yang, Jae Seung
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Vaccine Society 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6082675/
https://ncbi.nlm.nih.gov/pubmed/30112349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7774/cevr.2018.7.2.104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados